Evidence mapPaperPMID 41034571Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2025

Investigation of risk factors for osteoporosis with a focus on hypertension and estimation of the causal effect of hypertension on osteoporosis using causal forest.

Takuya Uematsu, Shuko Nojiri, Wataru Urasaki, Yuji Nishizaki

Abstract read
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Response to the correspondence entitled "Mean arterial pressure and DXA-defined osteoporosis: a comment on Uematsu et al."Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  3. Mean arterial pressure and DXA-defined osteoporosis: a comment on Uematsu et al.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Takuya UematsuClinical Translational Science, Juntendo University School of Medicine Graduate School of Medicine, Tokyo, Japan.
Shuko NojiriMedical Technology Innovation Center, Juntendo University, Tokyo, Japan.
Wataru UrasakiDepartment of Information Science, Tokyo University of Science, Chiba, Japan.
Yuji NishizakiClinical Translational Science, Juntendo University School of Medicine Graduate School of Medicine, Tokyo, Japan. ynishiza@juntendo.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study aimed to comprehensively investigate the factors that most significantly increase the likelihood of developing osteoporosis, which is of great importance for aging populations. To this end, we focus on hypertension (HT) and examine its interaction and causal effect on osteoporosis. Using an administrative claims database, a nested case-control study and time-to-event analysis were conducted focusing on Japanese individuals aged ≥65 years. The results of the nested case-control study showed that rheumatoid arthritis (RA) had the highest odds ratio (OR = 1.961, 95% CI = 1.85-2.078), followed by HT (OR = 1.722, 95% CI = 1.659-1.787). In the time-to-event analysis, RA had the highest hazard ratio (HR = 2.133, 95% CI = 1.972-2.308), followed by chronic kidney disease (CKD) (HR = 1.473, 95% CI = 1.354-1.602), chronic obstructive pulmonary disease (HR = 1.46, 95% CI = 1.323-1.611), and HT (HR = 1.269, 95% CI = 1.21-1.331). Additionally, significant interactions were observed when HT co-existed with CKD, disorders of lipoprotein metabolism and other lipidemias (DLM), and RA. Moreover, the summary causal tree results of the conditional average treatment effect (CATE) using a causal inference approach revealed that the subgroup with DLM = 0, diabetes mellitus (DM) = 0, and RA = 0 exhibited the highest estimated CATE of 0.372, suggesting a strong independent causal effect of HT on osteoporosis in this group.

Indexed as

HypertensionOsteoporosisAgedAged, 80 and overArthritis, RheumatoidCase-Control StudiesFemaleHumansMaleRenal Insufficiency, ChronicRisk FactorsAdministrative claim databaseConditional average treatment effectHypertensionOsteoporosisRisk

Identifiers

PMID41034571
PMCPMC12678188

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.